CN Stock MarketDetailed Quotes

688273 Nanjing Medlander Medical Technology

Watchlist
  • 19.50
  • -0.54-2.69%
Noon Break Apr 19 11:29 CST
1.96BMarket Cap18.07P/E (TTM)

Nanjing Medlander Medical Technology Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
(Q3)Mar 31, 2022
(FY)Dec 31, 2021
(Q9)Sep 30, 2021
(Q6)Jun 30, 2021
Total operating revenue
-2.64%290.46M
11.61%204.4M
46.34%109.12M
10.32%376.89M
29.36%298.32M
18.83%183.13M
23.07%74.57M
1.52%341.64M
-0.51%230.61M
154.11M
Operating revenue
-2.64%290.46M
11.61%204.4M
46.34%109.12M
10.32%376.89M
29.36%298.32M
18.83%183.13M
23.07%74.57M
1.52%341.64M
-0.51%230.61M
--154.11M
Total operating cost
4.06%220.53M
14.09%157.96M
50.40%79.57M
15.15%272.01M
35.53%211.92M
36.06%138.45M
29.36%52.91M
7.49%236.22M
156.37M
101.76M
Operating cost
-13.23%85.56M
-4.83%64.77M
100.86%40.24M
28.15%118.53M
60.09%98.61M
71.31%68.06M
42.44%20.03M
15.33%92.49M
19.41%61.59M
--39.73M
Operating tax surcharges
23.00%3.61M
45.67%2.68M
27.52%1.1M
-13.86%4.25M
-14.60%2.93M
-32.15%1.84M
-12.37%862.21K
0.65%4.93M
--3.43M
--2.71M
Operating expense
6.41%66.11M
15.69%44.27M
9.35%19.15M
14.11%84.14M
33.23%62.13M
27.73%38.26M
46.45%17.52M
7.70%73.74M
--46.63M
--29.96M
Administration expense
44.82%33.17M
63.14%22.6M
48.67%9.82M
15.10%32.72M
17.31%22.91M
10.16%13.85M
26.29%6.61M
15.91%28.43M
--19.53M
--12.58M
Financial expense
-310.31%-10.78M
-201.60%-5.16M
-317.58%-2.87M
-1,406.77%-8.96M
-560.05%-2.63M
-297,565.44%-1.71M
-1,150.62%-687.93K
-289.57%-594.62K
---397.9K
--575.71
-Interest expense (Financial expense)
67.33%314.31K
65.81%214.04K
68.75%109.48K
97.07%300.94K
-6.88%187.84K
13.53%129.09K
179.27%64.88K
-65.62%152.71K
--201.72K
--113.7K
-Interest Income (Financial expense)
-377.79%-11.14M
-190.50%-5.38M
-295.70%-3M
-1,092.45%-9.31M
-272.00%-2.33M
-1,293.77%-1.85M
-736.83%-759.21K
-308.41%-780.53K
---626.68K
---132.78K
Research and development
53.18%42.86M
58.75%28.81M
41.40%12.13M
11.04%41.34M
9.38%27.98M
8.10%18.15M
-1.57%8.58M
-9.97%37.23M
--25.58M
--16.79M
Credit Impairment Loss
85.09%-188.82K
88.05%-131.77K
-43.99%-200.17K
-437.71%-2.92M
-630.82%-1.27M
-819.01%-1.1M
-223.74%-139.01K
-574.52%-542.9K
---173.25K
---119.98K
Asset Impairment Loss
----
----
----
-106.15%-348.71K
----
----
----
59.27%-169.16K
---169.16K
---169.16K
Other net revenue
Fair value change income
--352.12K
157.93%361.39K
----
----
----
--140.11K
----
----
--1.15M
----
Invest income
158.63%10.63M
532.57%8.19M
1,108.21%4.82M
67.17%7.97M
134.54%4.11M
-21.85%1.3M
50.66%399.02K
27.17%4.77M
--1.75M
--1.66M
-Including: Investment income associates
-366.39%-308.6K
-240.61%-215.49K
-305.34%-142.99K
37.37%42.84K
-90.91%-66.17K
-195.04%-63.27K
24.23%69.63K
-96.24%31.19K
---34.66K
--66.57K
Asset deal income
--3.73K
----
----
----
----
238.06%842.15
--842.15
21,703.58%307.03K
--319.22K
---609.97
Other revenue
-41.00%16.92M
0.24%11.91M
36.79%3.63M
79.36%36.28M
96.00%28.68M
3.39%11.88M
-14.40%2.66M
10.66%20.23M
--14.63M
--11.49M
Operating profit
-17.20%97.64M
17.35%66.78M
53.81%37.8M
12.19%145.86M
28.52%117.92M
-12.74%56.91M
6.07%24.58M
-5.99%130.01M
-11.88%91.75M
65.22M
Add:Non operating Income
-13.94%80.94K
-20.47%59.92K
-55.15%13.39K
709.47%108.8K
599.80%94.06K
595.03%75.34K
-18.62%29.85K
-47.67%13.44K
--13.44K
--10.84K
Less:Non operating expense
4,156.15%304.67K
1,284.89%149.94K
181.39%5.86K
-75.78%70.28K
-97.43%7.16K
-95.89%10.83K
-98.73%2.08K
-28.00%290.2K
--278.18K
--263.41K
Total profit
-17.45%97.42M
17.06%66.69M
53.67%37.81M
12.46%145.9M
28.99%118M
-12.30%56.97M
6.78%24.61M
-5.94%129.73M
-11.83%91.48M
64.96M
Less:Income tax cost
-8.09%10.85M
7.31%6.03M
111.71%4.42M
63.02%16.36M
-10.70%11.8M
-41.48%5.62M
-34.27%2.09M
-39.41%10.04M
--13.22M
--9.6M
Net profit
-18.49%86.57M
18.13%60.66M
48.29%33.39M
8.22%129.53M
35.69%106.2M
-7.25%51.35M
13.34%22.52M
-1.37%119.7M
-14.01%78.27M
55.37M
Net profit from continuing operation
-18.49%86.57M
18.13%60.66M
48.29%33.39M
8.22%129.53M
35.69%106.2M
-7.25%51.35M
13.34%22.52M
-1.37%119.7M
--78.27M
--55.37M
Less:Minority Profit
-77.41%1.83M
-61.13%1.82M
-29.76%1.01M
478.26%7.6M
1,016.57%8.11M
4,917.10%4.68M
445.90%1.43M
327.84%1.31M
--725.9K
--93.35K
Net profit of parent company owners
-13.62%84.74M
26.08%58.84M
53.60%32.39M
3.00%121.93M
26.51%98.1M
-15.56%46.67M
3.95%21.08M
-2.91%118.38M
-14.93%77.54M
--55.27M
Earning per share
Basic earning per share
-33.04%0.8445
-5.74%0.5866
15.23%0.3239
-7.30%1.4632
21.98%1.2612
-15.56%0.6223
3.92%0.2811
-2.92%1.5784
--1.0339
--0.737
Diluted earning per share
-33.04%0.8445
-5.74%0.5866
15.23%0.3239
-7.30%1.4632
21.98%1.2612
-15.56%0.6223
3.92%0.2811
-2.92%1.5784
--1.0339
--0.737
Other composite income
Total composite income
-18.49%86.57M
18.13%60.66M
48.29%33.39M
8.22%129.53M
35.69%106.2M
-7.25%51.35M
13.34%22.52M
-1.37%119.7M
78.27M
55.37M
Total composite income of parent company owners
-13.62%84.74M
26.08%58.84M
53.60%32.39M
3.00%121.93M
26.51%98.1M
-15.56%46.67M
3.95%21.08M
-2.91%118.38M
--77.54M
--55.27M
Total composite income of minority owners
-77.41%1.83M
-61.13%1.82M
-29.76%1.01M
478.26%7.6M
1,016.57%8.11M
4,917.10%4.68M
445.90%1.43M
327.84%1.31M
--725.9K
--93.35K
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022(Q3)Mar 31, 2022(FY)Dec 31, 2021(Q9)Sep 30, 2021(Q6)Jun 30, 2021
Total operating revenue -2.64%290.46M11.61%204.4M46.34%109.12M10.32%376.89M29.36%298.32M18.83%183.13M23.07%74.57M1.52%341.64M-0.51%230.61M154.11M
Operating revenue -2.64%290.46M11.61%204.4M46.34%109.12M10.32%376.89M29.36%298.32M18.83%183.13M23.07%74.57M1.52%341.64M-0.51%230.61M--154.11M
Total operating cost 4.06%220.53M14.09%157.96M50.40%79.57M15.15%272.01M35.53%211.92M36.06%138.45M29.36%52.91M7.49%236.22M156.37M101.76M
Operating cost -13.23%85.56M-4.83%64.77M100.86%40.24M28.15%118.53M60.09%98.61M71.31%68.06M42.44%20.03M15.33%92.49M19.41%61.59M--39.73M
Operating tax surcharges 23.00%3.61M45.67%2.68M27.52%1.1M-13.86%4.25M-14.60%2.93M-32.15%1.84M-12.37%862.21K0.65%4.93M--3.43M--2.71M
Operating expense 6.41%66.11M15.69%44.27M9.35%19.15M14.11%84.14M33.23%62.13M27.73%38.26M46.45%17.52M7.70%73.74M--46.63M--29.96M
Administration expense 44.82%33.17M63.14%22.6M48.67%9.82M15.10%32.72M17.31%22.91M10.16%13.85M26.29%6.61M15.91%28.43M--19.53M--12.58M
Financial expense -310.31%-10.78M-201.60%-5.16M-317.58%-2.87M-1,406.77%-8.96M-560.05%-2.63M-297,565.44%-1.71M-1,150.62%-687.93K-289.57%-594.62K---397.9K--575.71
-Interest expense (Financial expense) 67.33%314.31K65.81%214.04K68.75%109.48K97.07%300.94K-6.88%187.84K13.53%129.09K179.27%64.88K-65.62%152.71K--201.72K--113.7K
-Interest Income (Financial expense) -377.79%-11.14M-190.50%-5.38M-295.70%-3M-1,092.45%-9.31M-272.00%-2.33M-1,293.77%-1.85M-736.83%-759.21K-308.41%-780.53K---626.68K---132.78K
Research and development 53.18%42.86M58.75%28.81M41.40%12.13M11.04%41.34M9.38%27.98M8.10%18.15M-1.57%8.58M-9.97%37.23M--25.58M--16.79M
Credit Impairment Loss 85.09%-188.82K88.05%-131.77K-43.99%-200.17K-437.71%-2.92M-630.82%-1.27M-819.01%-1.1M-223.74%-139.01K-574.52%-542.9K---173.25K---119.98K
Asset Impairment Loss -------------106.15%-348.71K------------59.27%-169.16K---169.16K---169.16K
Other net revenue
Fair value change income --352.12K157.93%361.39K--------------140.11K----------1.15M----
Invest income 158.63%10.63M532.57%8.19M1,108.21%4.82M67.17%7.97M134.54%4.11M-21.85%1.3M50.66%399.02K27.17%4.77M--1.75M--1.66M
-Including: Investment income associates -366.39%-308.6K-240.61%-215.49K-305.34%-142.99K37.37%42.84K-90.91%-66.17K-195.04%-63.27K24.23%69.63K-96.24%31.19K---34.66K--66.57K
Asset deal income --3.73K----------------238.06%842.15--842.1521,703.58%307.03K--319.22K---609.97
Other revenue -41.00%16.92M0.24%11.91M36.79%3.63M79.36%36.28M96.00%28.68M3.39%11.88M-14.40%2.66M10.66%20.23M--14.63M--11.49M
Operating profit -17.20%97.64M17.35%66.78M53.81%37.8M12.19%145.86M28.52%117.92M-12.74%56.91M6.07%24.58M-5.99%130.01M-11.88%91.75M65.22M
Add:Non operating Income -13.94%80.94K-20.47%59.92K-55.15%13.39K709.47%108.8K599.80%94.06K595.03%75.34K-18.62%29.85K-47.67%13.44K--13.44K--10.84K
Less:Non operating expense 4,156.15%304.67K1,284.89%149.94K181.39%5.86K-75.78%70.28K-97.43%7.16K-95.89%10.83K-98.73%2.08K-28.00%290.2K--278.18K--263.41K
Total profit -17.45%97.42M17.06%66.69M53.67%37.81M12.46%145.9M28.99%118M-12.30%56.97M6.78%24.61M-5.94%129.73M-11.83%91.48M64.96M
Less:Income tax cost -8.09%10.85M7.31%6.03M111.71%4.42M63.02%16.36M-10.70%11.8M-41.48%5.62M-34.27%2.09M-39.41%10.04M--13.22M--9.6M
Net profit -18.49%86.57M18.13%60.66M48.29%33.39M8.22%129.53M35.69%106.2M-7.25%51.35M13.34%22.52M-1.37%119.7M-14.01%78.27M55.37M
Net profit from continuing operation -18.49%86.57M18.13%60.66M48.29%33.39M8.22%129.53M35.69%106.2M-7.25%51.35M13.34%22.52M-1.37%119.7M--78.27M--55.37M
Less:Minority Profit -77.41%1.83M-61.13%1.82M-29.76%1.01M478.26%7.6M1,016.57%8.11M4,917.10%4.68M445.90%1.43M327.84%1.31M--725.9K--93.35K
Net profit of parent company owners -13.62%84.74M26.08%58.84M53.60%32.39M3.00%121.93M26.51%98.1M-15.56%46.67M3.95%21.08M-2.91%118.38M-14.93%77.54M--55.27M
Earning per share
Basic earning per share -33.04%0.8445-5.74%0.586615.23%0.3239-7.30%1.463221.98%1.2612-15.56%0.62233.92%0.2811-2.92%1.5784--1.0339--0.737
Diluted earning per share -33.04%0.8445-5.74%0.586615.23%0.3239-7.30%1.463221.98%1.2612-15.56%0.62233.92%0.2811-2.92%1.5784--1.0339--0.737
Other composite income
Total composite income -18.49%86.57M18.13%60.66M48.29%33.39M8.22%129.53M35.69%106.2M-7.25%51.35M13.34%22.52M-1.37%119.7M78.27M55.37M
Total composite income of parent company owners -13.62%84.74M26.08%58.84M53.60%32.39M3.00%121.93M26.51%98.1M-15.56%46.67M3.95%21.08M-2.91%118.38M--77.54M--55.27M
Total composite income of minority owners -77.41%1.83M-61.13%1.82M-29.76%1.01M478.26%7.6M1,016.57%8.11M4,917.10%4.68M445.90%1.43M327.84%1.31M--725.9K--93.35K
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
%Chg